Tag Archive for: CALR mutations

What Is Precision Medicine for MPNs?

What Is Precision Medicine for MPNs? from Patient Empowerment Network on Vimeo.

Myeloproliferative neoplasm (MPN) patients have the option of precision medicine in the treatment toolbox. Dr. Kristen Pettit from Rogel Cancer Center shares insight about some forms of precision medicine, disease-specific factors, and potential future treatments for personalized medicine.

See More From the MPN TelemEDucation Resource Center

Related Resources:

What Is the Role of Next-Generation Sequencing in MPNs?

What Is Next Generation Sequencing for MPNs?

Are Mobile-Optimized Tools Impacting MPN Care?


Transcript:

Dr. Kristen Pettit:

Precision medicine or personalized medicine can take many forms in the MPN field, certainly decisions about whether to consider something like a stem cell transplant or personalized based on disease-specific factors such as the prognostic risk of the individual disease and based on person-specific factors, for example, the patient’s symptoms, their quality of life, their goals, and their other medical issues. Similar personalized factors go into other treatment decisions such as whether or not to start a JAK inhibitor or other treatment as well.

In the future, I think MPN care will continue to see more personalization, perhaps even involving information like specific genetic mutations, for example, there are drugs that are in development that may target on mutant calreticulin, so those might be possibly more specific treatments for folks just with those CALR mutations.